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ORIGINAL ARTICLE
Adiposity has differing associations with incident coronary heart
disease and mortality in the Scottish population: cross-sectional
surveys with follow-up
JW Hotchkiss, CA Davies and AH Leyland
OBJECTIVE: Investigation of the association of excess adiposity with three different outcomes: all-cause mortality, coronary
heart disease (CHD) mortality and incident CHD.
DESIGN: Cross-sectional surveys linked to hospital admissions and death records.
SUBJECTS: 19 329 adults (aged 18–86 years) from a representative sample of the Scottish population.
MEASUREMENTS: Gender-stratiﬁed Cox proportional hazards models were used to estimate hazard ratios (HRs) for all-cause
mortality, CHD mortality and incident CHD. Separate models incorporating the anthropometric measurements body mass index
(BMI), waist circumference (WC) or waist–hip ratio (WHR) were created adjusted for age, year of survey, smoking status and alcohol
consumption.
RESULTS: For both genders, BMI-deﬁned obesity (X30 kgm 2) was not associated with either an increased risk of all-cause
mortality or CHD mortality. However, there was an increased risk of incident CHD among the obese men (hazard ratio (HR)¼ 1.78;
95% conﬁdence interval¼ 1.37–2.31) and obese women (HR¼ 1.93; 95% conﬁdence interval¼ 1.44–2.59). There was a similar
pattern for WC with regard to the three outcomes; for incident CHD, the HR¼ 1.70 (1.35–2.14) for men and 1.71 (1.28–2.29) for
women in the highest WC category (men X102 cm, women X88 cm), synonymous with abdominal obesity. For men, the highest
category of WHR (X1.0) was associated with an increased risk of all-cause mortality (1.29; 1.04–1.60) and incident CHD (1.55;
1.19–2.01). Among women with a high WHR (X0.85) there was an increased risk of all outcomes: all-cause mortality (1.56;
1.26–1.94), CHD mortality (2.49; 1.36–4.56) and incident CHD (1.76; 1.31–2.38).
CONCLUSIONS: In this study excess adiposity was associated with an increased risk of incident CHD but not necessarily death. One
possibility is that modern medical intervention has contributed to improved survival of ﬁrst CHD events. The future health burden
of increased obesity levels may manifest as an increase in the prevalence of individuals living with CHD and its consequences.
International Journal of Obesity (2013) 37, 732–739; doi:10.1038/ijo.2012.102; published online 3 July 2012
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INTRODUCTION
The high prevalence of obesity in Scotland1 and other developed
countries2 raises concerns over its health impact. The relationship
between overall body fat proportion, as summarised by body
mass index (BMI), and all-cause mortality has been established
by many studies to be U-shaped, with the nadir within the
normal range (18.5–25 kgm 2).3,4 However, some studies using
contemporary population samples have identiﬁed an apparent
attenuation of this association.5–8 In these analyses, overweight
(25–30 kgm 2) has been identiﬁed to be borderline protective, or
even protective, and obesity (430 kgm 2) was only associated
with an increased risk of mortality once BMI exceeded 35 kgm 2.
Flegal et al.,6,9 upon comparing cohorts recruited at different
times, suggested that the inﬂuence of obesity on mortality, and
cardiovascular disease (CVD) mortality, may have decreased over
time. Similarly, on comparison of two Canadian studies, one
recruited in the 1980s5 and the other in the 1990s,7 excess
adiposity was found to have a reduced association with mortality
in the later study.
It has been suggested that improvements in medical care,
particularly in relation to CVD, may be one of the contributors to
the diminished impact of obesity on mortality over time.6,9
Advances in treatment account for at least half the recent decline
in coronary heart disease (CHD) mortality.10,11 In a recent study of
the Scottish Health Survey (SHeS) Cohort,12 we identiﬁed obesity
to be associated with an increased risk of mortality once BMI was
440 kgm 2. We hypothesised that if medical improvements are,
in part, weakening the association between increased adiposity
and mortality, then a stronger positive association would exist
for incident CHD than for mortality. We therefore examined the
association between BMI, as well as waist circumference (WC), and
waist–hip ratio (WHR) (indices of abdominal adiposity), with the
three outcomes of all-cause mortality, CHD mortality and incident
CHD within this same Scottish population sample, the SHeS
Cohort.
MATERIALS AND METHODS
Survey method and subjects
The SHeSs 1995, 1998 and 2003 are cross-sectional nationally representa-
tive surveys designed to provide information on the health and health-
related behaviours of people living in private households in Scotland;
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details are described elsewhere.13–16 Samples were selected using a multi-
stage stratiﬁed clustered probability sampling design. The surveys were
age limited in 1995 (16–64 years) and 1998 (2–74 years). Data were
collected during two household visits: ﬁrst by an interviewer (where
BMI was determined), then by a nurse. Body weight was measured to the
nearest 100 g using electronic scales; an estimate was requested from
respondents exceeding the scales’ upper limit of 130 kg. Height was
measured to the nearest millimetre using a stadiometer. Waist and hip
circumferences were measured during the nurse visit using a tape with an
insertion buckle. Both were taken at least twice and recorded to the
nearest millimetre to provide a mean. The waist was deﬁned as the
midpoint between the lower rib and the upper margin of the iliac crest.
The hips were measured at the widest circumference around the buttocks
below the iliac crest. Pregnant women and participants who were chair
bound were excluded from all the above measurements.
Measures
Anthropometric. BMI was calculated as weight (kg) divided by the square
of the height (m2). Established cut-off points for BMI were used:
underweight (o18.5 kgm 2), desirable weight (18.5–o25 kgm 2), over-
weight (25–o30 kgm 2) and obese (X30 kgm 2).17 WC was deﬁned in
gender-speciﬁc low, reference, moderate and high (abdominal obesity)
categories (for men: o79 cm, 79–o94 cm, 94–o102 cm and X102 cm,
and for women: o68 cm, 68–o80 cm, 80–o88 cm and X88 cm,
respectively).18,19 WHR (WC divided by hip circumference) was
categorised as low, reference, moderate and high (abdominal obesity)
separately for men (o0.85, 0.85–o0.95, 0.95–o1 and X1) and women
(o0.7, 0.7–o0.8, 0.8–o0.85 and X0.85). WC and WHR included cut-offs
recommended by a WHO consultation; the upper limits of the second
lowest categories (reference) have been associated with increased health
risk.17
Covariates. Age was recorded as age at the time of interview. Smoking
status was categorised as never smoker, ex-smoker, light smoker (0–o10
cigarettes per day), moderate smoker (10–o20 cigarettes per day) and
heavy smoker (X20 cigarettes per day). Pipe and cigar smokers were
included with light smokers. Alcohol consumption was deﬁned as never or
very occasional drinker, ex-drinker, 0–o7 units per week, 7–o14 units per
week, 14–o21 units per week, 21–o28 units per week andX28 units per
week (1 unit¼ 10ml ethanol). For women the last two categories were
merged owing to low numbers. Two socioeconomic covariates were used:
individual Registrar General’s occupational social class and 2001 Carstairs
score quintiles, an area-based deprivation measure.20
Outcome measures
These surveys, with participants’ consent, have been linked to a national
database of deaths (till December 2008) and the Scottish Morbidity
Records.16 The latter are a patient-based database of acute hospital
discharges from 1981 to December 2008. Three outcomes were
investigated: all-cause mortality, CHD mortality deﬁned by international
classiﬁcation of disease codes (ICD-9 410-414 and ICD-10 I20-I25) and
incident CHD (fatal and non-fatal events). The latter was deﬁned as ﬁrst
hospital admission, or death, using the same ICD codes plus the surgical
interventions coronary artery bypass grafting and percutaneous
transluminal coronary angioplasty.
Sample
Response for the interview stage of the survey, where BMI was determined,
declined from 81% in 1995 to 76% in 1998 and ﬁnally to 60% in 2003. The
proportion of these progressing to the nurse interview, where WC and
WHR were ascertained, also declined from 88% in 1995 to 67% in 2003.
Individuals who had consented to data linkage (approximately 92%), were
between 18 and 85 years of age, had no prior hospital admissions for CHD
or stroke, and had complete data were included in analyses; Figure 1
summarises the combined sample derivation. Of the ﬁrst event, CHD
deaths in this sample, 36% had post mortems completed and 76%
occurred without prior hospitalisation (numerator, CHD death with no
admission; denominator, CHD death with no admission plus all deaths
within 12 months of admission).
Statistical analyses
For each of the anthropometric measures Cox proportional hazards models
were used to estimate HRs for the three outcomes. Models were ﬁtted
within a multilevel framework to account for the data hierarchy of
individuals within postcodes. The timescale was taken as time since
interview (months) and censoring occurred at 31 December 2008. Models
were adjusted for age (centred), smoking status, alcohol consumption and
survey cohort. Additional adjustments were then made using either social
class or area of deprivation. The second lowest category was used as
referent for the anthropometric covariates; all other categorical covariates
used the ﬁrst category. A signiﬁcant interaction between BMI and gender
prompted stratiﬁcation of all analyses by sex. Survival curves for each
gender, and outcome, were generated using the Kaplan–Meier method
with formal testing using the log-rank test. Adherence to the proportional
hazards assumption was investigated by incorporation of time-dependent
covariates in the models and by plotting smoothed Schoenfeld residuals
against time; no violations of the assumption were identiﬁed. Sensitivity
Combined response to
Scottish Health Surveys
1995, 1998 & 20031
(n =25 127)
Consent to data linkage
(n =23 093, deaths=1827)
Exclude missing (sequential):
• BMI n =21342, deaths=215
• Alcohol n =14, deaths=2
• Smoking n =4, deaths=0
Waist circumference
(n =17 117, deaths=1209)
Exclude missing (sequential):
• WHR n=43712, deaths=288
• Alcohol n=14, deaths=1
• Smoking n=3, deaths=0
Exclude missing (sequential):
• WC n =43472, deaths=285
• Alcohol n =14, deaths=1
• Smoking n =3, deaths=0
Waist-hip ratio
(n =17 093, deaths=1206)
Body mass index
(n =19 329, deaths=1278)
18 to 85 years. No prior CHD or Stroke
(n =21 481, deaths=1495)
Exclude prior CHD or Stroke
(n =945, deaths=277)
Exclude <18 and >85 years
(n =667, deaths=55)
No consent to data linkage
(n =2034)
Figure 1. Flow diagram of the derivation of the final combined sample size from the Scottish Health Survey Cohort for each anthropometric
measure used in analyses. 1All respondents over 16 years of age 2includes 212 pregnant women.
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analyses excluding the ﬁrst 3 or 5 years of follow-up were performed, as
well as limiting analyses to individuals with complete data for the
anthropometric measures. All statistical tests were two-tailed and statistical
signiﬁcance was taken as Po0.05. All the aforementioned analyses were
performed using SAS v9.2 (SAS Institute Inc., Cary, NC, USA) and MLwiN
v2.11(ref. 21) statistical software.
The anthropometric measures were also ﬁtted as continuous variables
using a fractional polynomial algorithm in fully adjusted, gender-stratiﬁed,
single-level models.22 Command mfp in Stata/IC 10.1 (StataCorp LP.,
College Station, TX, USA) was used to ﬁt the most appropriate ﬁrst-degree,
or second-degree, fractional polynomial to the data using power
transformation(s) from, among others, the reciprocal, logarithm, square,
cube and linear (no transformation). Age was simultaneously ﬁtted using
the same selection process.
RESULTS
During a median follow-up of 10.1 years (extremes 6 days to 13.8
years; men¼ 86 012 and women¼ 112 804 person-years at risk)
there were 757 deaths among men and 738 deaths among
women (crude death rate of 8.8 for men and 6.5 for women per
1000 person-years) (Table 1). The crude CHD death rate was 1.5
and 1.0 per 1000 person-years and the crude incident CHD (fatal
and non-fatal) rate was 6.1 and 3.2 per 1000 person-years for men
and women, respectively. The risk of death, CHD death and
incident CHD was greater for men than for women (Figure 2).
Baseline data stratiﬁed by gender are presented in Table 1.
The anthropometric measures had the highest proportion of
missing data, which increased from 1995 to 2003 and was greatest
for the WC and WHR measures (Table 1, Figure 1 and
Supplementary Table 1). The proportion of women in each survey
was greater than men; in the combined sample 56.6% were
women. The proportion classed as obese by BMI increased from
16.7% in 1995 to 22.1% in 2003. There was a similar increasing
trend for the size of the highest WC and WHR categories. For the
complete case samples used in the main analyses, on the basis of
BMI (X30 kgm 2), 20.6% of men and 22.8% of women were
obese (Tables 2 and 3). On the basis of WC (menX102 cm,
womenX88 cm) 22.0% of men and 29.9% of women had
abdominal obesity. WHR (menX1.0, womenX0.85) classiﬁed
9.4% of men and 25.2% of women as having abdominal obesity.
For both genders there was no increase in risk of all-cause death
associated with BMI-deﬁned obesity (men adjusted HR¼ 0.82;
95% conﬁdence interval¼ 0.67–1.01 and women 0.93; 0.75–1.15)
(Tables 2 and 3). A similar ﬁnding was determined for CHD death
except that the estimates were 41, although still non-signiﬁcant.
Similarly, overweight, based on BMI, was not associated with
altered risk, except for all-cause mortality in men, where it was
protective (0.64; 0.54–0.77). In contrast, the risk of an incident CHD
event was increased for men and women for both overweight and
obesity, as deﬁned by BMI. The highest risk was among the obese:
for men the adjusted HR¼ 1.78 (1.37–2.31) and for women the
Table 1. Baseline characteristics for the Scottish Health Surveys
Cohort sample stratified by gender
Men Women
Sample size 9320 12 161
All-cause deaths, n (%) 757 (8.1) 738 (6.1)
Coronary heart disease deaths, n (%) 132 (1.4) 112 (0.9)
Incident CHD, n (%) 511 (5.5) 362 (3.0)
Person-years of follow-up
Mortality 86 012 112 804
Incident CHD 84 155 111 464
Death rate/1000 person-yearsa 8.8 6.5
Coronary heart disease death
rate/1000 person-yearsa
1.5 1.0
Incident CHD event rate/1000
person-yearsa
6.1 3.2
Mean age (years) (s.d.) 44.6 (15.0) 45.1 (15.5)
Survey, n (%)
1995 3108 (33.3) 3914 (32.2)
1998 3331 (35.7) 4429 (36.4)
2003 2881 (30.9) 3818 (31.4)
BMI (kgm 2), n (%)
o18.5 (underweight) 84 (0.9) 201 (1.7)
18.5–o25 (desirable weight) 2983 (32.0) 4633 (38.1)
25–o30 (overweight) 3711 (39.8) 3511 (28.9)
X30 (obese) 1760 (18.9) 2464 (20.3)
Missing 782 (8.4) 1352 (11.1)
WC (cm), n (%)
M o79, W o68 (low) 719 (7.7) 978 (8.0)
M 79–o94, W 68–o80 (reference) 3477 (37.3) 3528 (29.0)
M 94–o102, W 80–o88 (moderate) 1743 (18.7) 2163 (17.8)
M X102, W X88 (high) 1677 (18.0) 2849 (23.4)
Missing 1704 (18.3) 2643 (21.7)
WHR, n (%)
M o0.8, W o0.65 (low) 1325 (14.2) 421 (3.5)
M 0.8–o0.9, W 0.65–o0.75
(reference)
4193 (45.0) 4339 (35.7)
M 0.9–o1, W 0.75–o0.85
(moderate)
1374 (14.7) 2347 (19.3)
M X1, W X0.85 (high) 717 (7.7) 2394 (19.7)
Missing 1711 (18.4) 2660 (21.9)
Smoking status, n (%)
Never smoker 3686 (39.5) 5431 (44.7)
Ex-smoker 2203 (23.6) 2609 (21.5)
Light smoker 871 (9.3) 860 (7.1)
Moderate smoker 1149 (12.3) 1744 (14.3)
Heavy smoker 1407 (15.1) 1508 (12.4)
Missing 4 (0) 9 (0.1)
Alcohol consumption, n (%)
Never/occasional drinker 297 (3.2) 908 (7.5)
Ex-drinker 346 (3.7) 560 (4.6)
0–o7 units/week 2645 (28.4) 6763 (55.6)
7–o14 units/week 1608 (17.3) 2252 (18.5)
14–o21 units/week 1423 (15.3) 971 (8.0)
21–o28 units/week 988 (10.6) 335 (2.8)
X 28 units/week 2004 (21.5) 361 (3.0)
Missing 9 (0.1) 11 (0.1)
Individual social class, n (%)
I/II—professional/managerial 2952 (31.7) 3295 (27.1)
III—skilled non-manual 944 (10.1) 3807 (31.3)
III—skilled manual 3131 (33.6) 1058 (8.7)
IV—partly skilled 1470 (15.8) 2189 (18.0)
V—unskilled 467 (5.0) 1098 (9.0)
Other 356 (3.8) 714 (5.9)
Table 1 (Continued )
Men Women
Carstairs quintile, n (%)
1—Least deprived 1742 (18.7) 2175 (17.9)
2 2057 (22.1) 2616 (21.5)
3 2060 (22.1) 2691 (22.1)
4 1673 (18.0) 2226 (18.3)
5—Most deprived 1768 (19.0) 2433 (20.0)
Missing 20 (0.2) 20 (0.2)
Abbreviations: BMI, body mass index; CHD, coronary heart disease, M, men;
W, women; WC, waist circumference; WHR, waist-hip ratio. Age limit was
18–85 years and no prior hospital admission for CHD or stroke. The missing
anthropometric data included pregnant women (n¼ 212), who were
excluded from all analyses. aCrude incidence rates.
Incident CHD and adiposity
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adjusted HR¼ 1.93 (1.44–2.59). For all-cause mortality there was
an increased risk of mortality associated with the underweight for
both genders.
Among men the adjusted HR estimates associated with
WC-deﬁned abdominal obesity increased from 1.10 (0.90–1.33)
for all-cause mortality, to 1.54 (0.98–2.44) for CHD mortality and
ﬁnally to 1.70 (1.35–2.14) for incident CHD (Table 2). This pattern
was repeated for women with HRs: respectively, 1.20 (0.97–1.47),
1.64 (0.95–2.81) and 1.71 (1.28–2.29) (Table 3). For both genders
there were no increased risks associated with moderate WC,
whereas a low WC was associated with a signiﬁcant increased risk
for all-cause mortality only. Men with a high WHR had an
increased risk of all-cause mortality and there was an increased
risk of incident CHD for men who were classed as having a
moderate WHR (1.38; 1.10–1.72) or high WHR (1.55; 1.19–2.01)
(Table 2). In contrast, women with moderate or high WHR had an
increased risk of suffering from all the three outcomes. For those
with a WHR denoting abdominal obesity the adjusted HRs
were 1.56 (1.26–1.94), 2.49 (1.36–4.56) and 1.76 (1.31–2.38) for
all-cause mortality, CHD mortality and incident CHD, respectively
(Table 3).
Adjustment for social class or deprivation had minimal impact
on the estimates for the anthropometric measures but did identify
inverse socioeconomic gradients for both genders and all
outcomes (data available on request). Sensitivity analyses exclud-
ing early follow-up or restricting the sample to complete cases for
anthropometric measures had minimal impact on estimates (data
available on request).
The fractional polynomial algorithm selected a U-shape (two-
term fractional polynomials) to best describe the association
between all-cause mortality and either continuous BMI or WC, for
both genders (Figure 3 and Supplementary Figure 1). For all the
other outcomes and for all models involving WHR, a linear
relationship was identiﬁed (Figure 3 and Supplementary Figures
2–6). A linear relationship for age was deemed most appropriate
in all models.
DISCUSSION
In the SHeS cohort, a nationally representative sample, the risk of
incident CHD was higher for individuals with greater adiposity,
irrespective of the anthropometric measure utilised. There
appeared to be a positive gradient in the strength of association
as the outcome changed from all-cause mortality to CHD mortality
to incident CHD. This would imply that excess adiposity was
associated with a signiﬁcant increase in the risk of a CHD event
occurring, but not of that event being fatal. Avoidance of fatality
during, and following, an event could be related to not only its
severity, a secular decline in which has been observed by some
studies,23,24 but also timely use of evidence-based medical
interventions that have been developed over recent decades.
A similar positive relationship between BMI, WC or WHR and
incident CHD has been identiﬁed by many studies.25–28 It is likely
that the contribution of obesity to CHD risk is mediated by the
major CVD risk factors of hypertension, dyslipidaemia and
diabetes. Overweight and obesity represent a clustering of these
risk factors and are associated with an increased risk of developing
these conditions.4,29 A substantial component of the increased risk
of CHD associated with excess adiposity is accounted for by such
risk factors.25,28 There may be an independent effect of obesity on
the risk of CHD.25,30
Although there was a tendency for an increased risk of CHD
mortality associated with excess adiposity according to all three
measures, in contrast to incident CHD, it was only signiﬁcant
according to WHR among women. Like incident CHD there was
evidence that there was a linear relationship between each of the
measures and CHD. Obesity has been associated with increased
risk for fatal CHD events by other studies,4,30 whereas for
intermediate categories, such as BMI overweight, the increase
has been shown to be more marginal.9,31 The ﬁndings for all-cause
mortality of a U-shaped relationship with BMI and WC are similar
to that found in our previous study, albeit this time stratiﬁed by
gender.12 Another study that incorporated the SHeS cohort also
found a decrease in the mortality risk associated with overweight
as deﬁned by BMI.8 Others have found there to be a non-
signiﬁcant decrease, or increase, in the association with
overweight.6,7,31 Some research contradicts this, having
identiﬁed that overweight, and also obesity, is associated with
an increased risk of all-cause mortality.4
Part of the lack of association between overweight according to
BMI and mortality is undoubtedly a consequence of its inability to
distinguish between fat mass and lean mass. It has limited
accuracy in the intermediate range (overweight) where there is a
greater heterogeneity in body fat proportion and this misclassiﬁes
many individuals, particularly men.32 This might explain the
comparatively lower risk for men associated with the overweight
categories for all outcomes seen in this study. The inability of BMI
to differentiate a lack of lean mass from a lack of fat mass33,34 may
partly inﬂuence the association of underweight with the increased
all-cause mortality seen here and elsewhere.6,7 The increased
association between underweight and all-cause mortality in part
reﬂects its principal association with non-cancer non-CVD
mortality, in particular respiratory disease.9,4,12
WC and WHR summarise overall fat proportion as well as fat
distribution; in particular they are proxies for visceral fat
accumulation. It is this that may be particularly deleterious in
relation to CVD via its role, along with dyslipidaemia, systemic
inﬂammation and insulin resistance, in metabolic syndrome.35 In
this study the three measures were qualitatively similar in their
association with incident CHD for both genders. WHR, although
identifying increased risk for all-cause mortality for men in the
highest category, was particularly effective in demonstrating
increased risk for both moderate and high-categorised women for
Figure 2. Kaplan–Meier survival curves stratified by gender for the outcomes of all-cause mortality, CHD mortality and incident CHD in the
Scottish Health Survey Cohort. Sample was age restricted to 18–85 years of age and excluded prior hospital admission for CHD or stroke.
Men, dashed lines; Women, solid lines.
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both mortality outcomes. Women in the high category for WHR
had an almost 150% increased risk of CHD mortality relative to the
normal category. A stronger association between abdominal
obesity and incident CHD for women, as seen in this study, has
previously been identiﬁed.25,26 The evidence as to the best
anthropometric measure in relation to mortality risk or CVD risk is
conﬂicting; many studies have found equivalence,3,27,28 others
have found either WC29 or WHR36 to be superior. It was not our
intention to compare the different measures formally and care
should be taken as the thresholds denoting excess adiposity
used here are not necessarily comparable. It would seem prudent
to consider more than one measure in epidemiological
studies. A further investigation of this data set could involve
use of WC or WHR in combination, or in mutual adjustment, with
BMI, as this may better capture the health risks of increased
adiposity.3
Figure 3. Functional form of the association of BMI with the relative hazard of (a) all-cause mortality, (b) CHD mortality, (c) incident CHD for
(i) men and (ii) women, estimated in a Cox proportional hazards model adjusted for age, smoking, alcohol consumption and survey year.
For (a) functions were fitted using two-term fractional polynomial functions with powers: (i) men ( 0.5,  0.5) and (ii) women ( 2,  2).
For (b) and (c) linear functions were selected. Functions standardised such that HR¼ 1 at the mean of the BMI reference category
(18.5–25 kgm 2): (i) men¼ 22.72 kgm 2 and (ii) women¼ 22.45 kgm 2. Dot–dash lines indicate 95% confidence interval.
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Despite adjusting our analyses for possible confounders there is
the potential for residual confounding to remain. As we were
interested in the impact of excess adiposity, we did not adjust for
the known intermediary CVD risk factors such as cholesterol and
blood pressure. Similarly, we did not adjust for physical activity, as
this will, in combination with diet, determine adiposity, although it
may have a separate cardio-protective effect. In previous analyses,
using this data set, we did not identify any major change in the
estimates for all-cause mortality following exclusion of smokers,
individuals over 64 years, early follow-up or pre-existing disease.12
Neither did sensitivity analyses using age as the timescale,
survey weights, multiple imputation for missing data (including
non-responders to the nurse) or limiting analyses to those
registered with general practitioners within Scotland. In this
study exclusion of early follow-up to account for the potential
effect of occult disease had minimal impact, as seen in other
studies.4,8
This study has many strengths, not least because it was
conducted on a contemporary, nationally representative sample
using anthropometric variables obtained by standardised mea-
surement. However, there are limitations, not least the likelihood
of measurement or responder bias. There is the potential for the
misclassiﬁcation of the cause of death or reason for hospital
admission; an assessment comparing the clinical coding in
Scottish Morbidity Records data to full medical records has
determined it to be 94% accurate for CHD, with 99% complete-
ness, for the period 2004–2006.37 As these were cross-sectional
surveys no information was available on past or future changes in
variables. For excess adiposity the length of time it has been
endured, age at which it occurred and any subsequent weight
loss may all be important in its relationship with mortality.38–41
There will be bias as a result of non-response to the original
interview and subsequent attrition because of non-consent to the
nurse visit and/or data linkage. The declining response proportion
across the surveys raises questions about their representativeness,
especially the 2003 SHeS. Assessment of non-response was not
possible using these SHeS data; in 2003 response was modestly
skewed towards those in less-deprived areas.42 Univariate analyses
identiﬁed that non-responders to the SHeS nurse interview, when
compared with responders, were more likely to be younger,
smokers and of lower socioeconomic status.43 Evidence is sparse
as to how non-participants differ from participants in health
surveys conducted in Britain; some less contemporary studies
indicate that they may be younger, of lower education or
socioeconomic status, lead unhealthier lifestyles and have higher
mortality.44,45 This is similar to more contemporary studies from
other countries.46–48
There is some evidence that overweight and obese individuals
with a BMI ofo35 kgm 2 may have a better chance of surviving
a CHD event than those of a normal weight.49 This may be
inﬂuenced by the ﬁnding that ﬁrst CHD events may occur at a
younger age in obese patients than those of normal weight.50,51
Clinicians have been demonstrated to pursue more aggressive
treatments, despite no difference in disease severity, in patients
with higher BMI50,52 and in younger patients.53 Obese patients
with CHD have higher risk factor levels such as hypertension and
hypercholesterolaemia that can be targeted by secondary
prevention. The inability of BMI to differentiate body
composition could also contribute to this obesity paraadox.54
Although medical treatment accounts for at least half of the
recent decline in CHD mortality, the remainder can be attributed
to population CVD-risk factor reductions.10,11 Obese people in
contemporary populations have a much lower prevalence of
major CVD risk factors (except diabetes) than 40 years ago,
although they still have the highest levels.55,56 A reduction in the
risk factors that mediate the association of obesity with CHD could
attenuate the mortality–adiposity relationship and the severity
of CHD events.
This study suggests that excess adiposity is associated with an
increased risk of incident CHD but not necessarily death. Modern
medical interventions may have contributed to improved survival of
ﬁrst CHD events. Suffering a non-fatal CHD event adversely affects an
individual’s quality of life57 and increases their risk of further CVD
incidents,58 with life expectancy halved after a diagnosis of acute
myocardial infarction.59 The future health burden of increased
population obesity levels may manifest as an increase in the
prevalence of individuals living with CHD and its consequences.
Public health policies to reduce obesity, such as Scotland’s route map
towards healthy weight,60 and other related CVD-risk factors, such as
hypertension and dyslipidaemia,61 are essential if the Scottish
population is to be spared heavy ﬁnancial and health burdens as a
consequence of CHD, now and in the future.
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